Higher expression levels of RAB3A, SYP, CAMK2A, and GABRA1, as well as lower expression levels of TYROBP and VSIG4, in glioma patients were associated with improved OS and DFS. The gene discussed is VSIG4; the disease is central nervous system cancer.